I did expect this news to move the needle.
There's now certainty about the CMO, delivery is secured.
Also we gained insight into the COG.
And ongoing non dilutive financing confirmed again.

Also, being connected to Samsung Biologics and them putting out a press release and gaining in share price is a plus too.
Already you can notice that Cydy is getting increased Asian online media attention. That can't hurt.

To be frank, I expected more fireworks. But, happy with any gain.